Helen K Angell

5PUBLICATIONS
63CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 13, 2026
Validation of Immunoscore for Prognostic Stratification in HPV-associated Oropharyngeal Cancer: An International Multicenter Study.

|Dec 18, 2025
Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High CST2 Expression and a Favorable Prognosis.

James Boyle, Jan Zaucha, Felicia Ng

|Feb 12, 2025
AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors.

Lillian L Siu, Sophie Postel-Vinay, Rafael Villanueva-Vázquez

|Oct 11, 2023
Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma.

Maria Secrier, Lara McGrath, Felicia Ng

|Aug 06, 2020
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Daniela Bruni, Helen K Angell, Jérôme Galon

Pageof 1

Frequent Collaborators

3 joint publications

Felicia Ng

3 joint publications

Jérôme Galon

2 joint publications

Amelia Raymond

2 joint publications

Ben S Sidders